Asston Pharmaceuticals Complete Financial Statements
APL • Review detailed financials to uncover trends, confirm thesis & journal trades
4 Years of Data
2025 - 2022
Complete Financial Data Export
Export complete financial statements for Asston Pharmaceuticals (APL).
Downloads include all available records across all periods.
For market performance, see the
APL stock price today
.
Profitability Ratios
Net Profit Margin
15.38%
2025 data
EBITDA Margin
23.08%
2025 data
Operating Margin
22.00%
2025 data
Return on Assets
14.29%
2025 data
Return on Equity
36.36%
2025 data
Balance Sheet Ratios
Current Ratio
13.50
2025 data
Debt to Equity
2.55
2025 data
Equity Ratio
39.29%
2025 data
Asset Turnover
0.93
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+40.0%
Year-over-Year
Equity Growth
+83.3%
Year-over-Year
Liabilities Growth
+40.0%
Year-over-Year
Operating Cash Flow Growth
+100.0%
Year-over-Year
Financing Cash Flow Growth
-125.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|---|
| Revenue | 0 | 26 | 16 | 7 | 11 |
| Expenses | 0 | 20 | 13 | 5 | 10 |
| EBITDA | 0 | 6 | 3 | 2 | 1 |
| Operating Profit Margin % | 0.00% | 22.00% | 16.00% | 23.00% | -4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 0 | 5 | 2 | 1 | 0 |
| Tax | 0 | 1 | 1 | 0 | 0 |
| Net Profit | 0 | 4 | 1 | 1 | 0 |
| Earnings Per Share (₹) | 0.00 | 6.14 | 2.37 | 1.89 | 11.62 |
Related Pages for Asston Pharmaceuticals
Additional stock information and data for APL
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| Total Assets | 28 | 20 | 14 | 10 |
| Current Assets | 27 | 18 | 11 | 7 |
| Fixed Assets | 1 | 1 | 1 | 1 |
| Capital Work in Progress | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 27 | 19 | 13 | 9 |
| LIABILITIES | ||||
| Total Liabilities | 28 | 20 | 14 | 10 |
| Current Liabilities | 2 | 2 | 2 | 1 |
| Non-Current Liabilities | ||||
| SHAREHOLDERS' EQUITY | ||||
| Total Equity | 11 | 6 | 2 | 1 |
| Share Capital | 6 | 1 | 1 | 1 |
| Reserves & Surplus | 5 | 6 | 1 | 0 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|
| Operating Activities | 0 | -4 | 0 | -1 |
| Investing Activities | 1 | 0 | -1 | 0 |
| Financing Activities | -1 | 4 | 1 | 1 |
| Net Cash Flow | 0 | 0 | 0 | 0 |